Drug Manufacturers—General Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 11 |  LLY Eli Lilly and Company Common Stock | 1244.79 USD | -0.80% | +4.46% | +3.65% | +75.20% | 1.17 T USD | ||
| 19 |  JNJ Johnson & Johnson Common Stock | 272.39 USD | +0.77% | +3.82% | +3.75% | +51.76% | 656.43 B USD | ||
| 22 |  ABBV AbbVie Inc. Common Stock | 264.89 USD | -0.02% | +5.93% | +2.41% | +25.96% | 468.09 B USD | ||
| 33 |  MRK Merck & Company, Inc. Common Stock | 150.77 USD | -1.15% | +10.97% | +15.04% | +73.24% | 371.98 B USD | ||
| 42 |  NVS Novartis AG | 158.25 USD | -0.38% | +3.94% | +1.07% | +24.80% | 301.97 B USD | ||
| 59 |  AMGN Amgen Inc. - Common Stock | 442.41 USD | +0.70% | +6.23% | +16.87% | +51.19% | 239.18 B USD | ||
| 84 |  GILD Gilead Sciences, Inc. - Common Stock | 146.66 USD | +0.37% | +5.67% | +11.95% | +27.63% | 181.85 B USD | ||
| 102 |  PFE Pfizer, Inc. Common Stock | 28.04 USD | -0.11% | +4.35% | +14.12% | +8.39% | 159.82 B USD | ||
| 113 |  BMY Bristol-Myers Squibb Company Common Stock | 67.11 USD | +0.13% | +3.87% | +7.55% | +39.93% | 137.09 B USD | ||
| 140 |  GSK GSK plc American Depositary Shares | 51.64 USD | -1.49% | +3.05% | -0.77% | +17.77% | 111.42 B USD | ||
| 141 |  SNY Sanofi - American Depositary Shares | 45.64 USD | -0.46% | +2.98% | +4.37% | -10.67% | 111.31 B USD | ||
| 370 |  ONC BeOne Medicines Ltd - American Depositary Shares | 372.62 USD | -0.49% | +3.37% | +13.69% | +18.03% | 42.37 B USD | ||
| 442 |  BIIB Biogen Inc. - Common Stock | 216.24 USD | -0.25% | +3.29% | +6.65% | +55.56% | 31.95 B USD | ||
| 1131 |  CGON CG Oncology, Inc. - Common stock | 78.17 USD | -2.05% | +1.69% | +10.24% | +79.45% | 6.93 B USD | ||
| 1139 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 102.78 USD | -4.80% | -8.22% | +12.08% | +220.49% | 6.81 B USD | ||
| 1496 |  MANE Veradermics, Incorporated Common Stock | 98.53 USD | -4.28% | -7.72% | -10.63% | +198.58% | 4.12 B USD | ||
| 1589 |  OGN Organon & Co. Common Stock | 13.73 USD | -0.22% | +0.07% | +1.55% | +89.12% | 3.61 B USD | ||
| 1682 |  MBX MBX Biosciences, Inc. - Common Stock | 66.29 USD | -0.06% | -2.96% | +6.51% | +364.87% | 3.19 B USD | ||
| 1892 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 49.46 USD | +2.53% | +1.81% | +21.20% | +88.85% | 2.37 B USD | ||
| 1935 |  GENB Generate Biomedicines, Inc. - Common Stock | 17.42 USD | +8.06% | +12.03% | +27.71% | +16.13% | 2.24 B USD |
News Drug Manufacturers—General Stocks
Will LQDA's Differentiated PAH Approach Drive Growth?
What’s Going On With Tempus AI Stock on Monday? - Tempus AI (NASDAQ:TEM)
Should You Buy Moderna Stock Following Its Cancer Breakthrough?
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
Is SYRE a Buy Now as Clinical Catalysts Clash With Valuation Risk?
Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD?
J&J's Strong Pipeline Momentum Offers Multiple Growth Catalysts Ahead
Gainers Drug Manufacturers—General Stocks
 VBIO Valion Bio, Inc. - Common stock | 0.15 | +25.00% |
GENB Generate Biomedicines, Inc. - Common Stock | 17.42 | +8.06% |
 DWTX Dogwood Therapeutics, Inc. - Common Stock | 2.65 | +6.43% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0600 | +6.38% |
 MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.80 | +5.26% |
 PTHS Pelthos Therapeutics Inc. Common Stock | 26.79 | +3.96% |
 QTTB Q32 Bio Inc. - Common Stock | 16.47 | +3.13% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 1.11 | +2.78% |
Losers Drug Manufacturers—General Stocks
 KAPA Kairos Pharma, Ltd. Common Stock | 0.23 | -20.69% |
 EXOZ eXoZymes Inc. - Common Stock | 6.71 | -9.08% |
 PLYX Polaryx Therapeutics, Inc. - Common Stock | 1.92 | -7.25% |
 QCLS Q/C Technologies, Inc. - Common Stock | 2.41 | -6.59% |
ORKA Oruka Therapeutics, Inc. - Common Stock | 102.78 | -4.80% |
MANE Veradermics, Incorporated Common Stock | 98.53 | -4.28% |
 UPB Upstream Bio, Inc. - Common Stock | 6.70 | -3.87% |
 OSTX OS Therapies Incorporated Common Stock | 1.53 | -3.77% |